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Introduction
Osteoporosis is considered to be a silent killer and as a 
result of its neglected status, especially in developing 
countries, the associated risks (i.e. bone fractures) 
are fast becoming a serious public health concern.1,2 
Osteoporosis affects nearly 200 million people 
worldwide, and with an estimated prevalence of 30% in 
postmenopausal women, bone mineral density (BMD) 
has become the single most important measurement 
in the evaluation and diagnosis of osteoporosis and 
its concomitant risks.3 The most significant sites for 
osteoporotic fractures are the spine and femoral neck, 
and according to Ivorra Cortés et al, the measurement 
of BMD at central sites (spine and hip) is the best 
prognostic factor of osteoporotic fractures.1,2,4 It is widely 
recognised that the strength of BMD measurement 
to predict future fractures is approximately threefold 
higher than the strength of serum cholesterol to predict 
cardiovascular diseases.5
There are various techniques to measure BMD, but 
the one that is currently used most is dual-energy 
X-ray absorptiometry (DXA). DXA is a high-precision 
BMD measurement and is considered to be the “gold 
standard”. However, it is expensive to purchase, is large 
and bulky, and the test measurements are costly. This 
makes it unsuitable for research studies. Therefore, it is 
advisable to consider alternative methods of identifying 
patients at high risk of developing osteoporosis. 
According to the World Health Organization (WHO), 
osteoporosis can be defined as “a systemic skeletal 
disease, characterised by a low bone mass and a 
micro-architectural deterioration of bone tissue, with a 
consequent increase in bone fragility and susceptibility 
to fractures”.6 It has been shown that the risk of fractures 
can be assessed from BMD measurements obtained 
from peripheral sites.7-9 One such example, the distal 
forearm, might act as a surrogate for the spine and hip. 
The current T-score criteria of the WHO to define 
osteoporosis (-2.5 SD) cannot be applied universally 
to BMD measurements of peripheral sites (such 
as the forearm). This is partially due to differences 
between the young reference populations, as well 
as different bone composition and age-related 
bone loss differences.10 Criteria for the selection cut-
off values for osteoporosis are based on data on 
Caucasian women. However, according to the latest 
Middle East and Africa regional audit (Epidemiology, 
Cost and Burden of Osteoporosis in 2011), released 
by the International Osteoporosis Foundation (IOF), 
black South African women appear to have similar 
vertebral BMD, and equal vertebral fractures, to those 
of Caucasian women, yet their hip BMD values still 
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remain significantly higher.11 Furthermore, in addition 
to an increased life expectancy (osteoporosis risk 
factor), lifestyle behaviours generally associated with 
favourable overall and bone health, are also lacking 
in black women, viz. low dietary calcium intake, and 
vitamin D and human immunodeficiency virus (HIV)/
acquired immune deficiency syndrome (AIDS) status.12
It is becoming more evident that osteoporosis is an equal 
opportunity disease. Therefore, the aim of this study 
was to establish a triage cut-off point or threshold for 
peripheral BMD, applicable to black postmenopausal 
women, that could be used as a screening method to 
differentiate between women with normal BMD, and 
those with possible central osteoporosis.
Method
Research design
This cross-sectional study was part of the South African 
arm of the Prospective Urban and Rural Epidemiology 
study (PURE). The PURE study, coordinated from 
the Population Health Research Institute, Ontario, 
Canada, is a longitudinal study designed to track the 
development of chronic lifestyle diseases, in urban 
and rural subjects, in approximately 20 developing 
countries.13  
Participants and experimental procedure
An availability sample of 184 black, urban 
postmenopausal women (> 47 years of age, and 
based on their follicle stimulating hormone status) from 
the North West province in South Africa was recruited 
for the study. Forearm bone density measurements 
(BMDDTX) were performed at the distal and ultra-
distal sites in the non-dominant arm, using a DTX-
200 peripheral DXA system (Osteometer MediTech, 
Hawthorn, California, USA). Conventional central bone 
density (BMDDXA) scans of the lumbar spine (L1-L4) 
and hip were performed using a Hologic Discovery-W 
(Hologic, Waltham, Massachusetts, USA). The results for 
each variable were calculated by the methodology 
described in the user manuals of each manufacturer. 
The following skeletal BMD results were recorded: distal 
(radius plus ulna) forearm, femoral neck, total hip, 
and lumbar spine (L1-L4). According to Patel et al, the 
distal site is defined as the 24 mm-long section of bone 
immediately proximal to the reference line where the 
separation between the radius and ulna is 8 mm.14 It 
consists of 87% cortical bone, and 13% trabecular 
bone. The ultra-distal site is defined as the area distal to 
the 8 mm reference line, and it contains 45% cortical, 
and 55% trabecular bone.14 The Osteometer DTX-200 
yields data on both the distal and ultra-distal sites. 
However, only the distal site values are reported. An 
availability sample out of the original group of women 
(n = 86) participated in the next phase, during which 
peripheral BMDDXA scans were performed to determine 
total forearm, distal forearm, and ultra-distal forearm 
bone densities. All BMD testing was performed by a 
licensed radiographer. A quality control (QC) scan was 
undertaken daily to ensure precision with the required 
coefficient of variation (CV). All scan analyses were 
performed by one operator. 
The study was approved by the Ethics Committee of 
the North-West University (Potchefstroom Campus, 
NWU-00016-10-A1), and the study protocol conforms to 
the ethical guidelines of the Declaration of Helsinki, as 
revised in 2004. All subjects gave informed consent.
Data analysis
Data were analysed using the Statistical Software for 
Social Sciences programme (SASW Statistics 18 for 
Windows, SPSS, Chicago, Illinois, USA). Descriptive vari-
ables are presented as mean ± standard deviation (SD) 
or mean ± standard error of mean. Independent t-tests 
were used to compare the variables between groups, 
to determine significant differences. Pearson’s correla-
tion coefficient was used to examine the correlation 
between distal forearm BMDDTX and BMDDXA measure-
ments, as well as between BMDDTX and central sites. 
The osteoporotic status of the women was defined by 
a BMDDXA T-score of ≤ -2.5 SD at any of the central sites. 
We calculated T-score values using the Caucasian ref-
erence range, due to a lack of an African reference 
range database. The percentage of subjects with a 
T-score of ≤ -2.5 SD at either hip or spine, was used to 
calculate the prevalence of overall central osteoporo-
sis in the population-based sample, as determined by 
BMDDXA scans. 
To give a representation of the range of BMDDTX, and to 
assess the agreement between the BMD as measured 
by the DXA and Osteometer, two plots were drawn up as 
described by Bland and Altman.15,16 Receiver operating 
curves (ROC) analysis was used as an evaluating 
graphical method to display the discriminatory 
accuracy of a diagnostic test, to distinguish between 
two populations (“diseased” and “non-diseased”). 
ROC curves are a trade-off between sensitivity (true-
positive rate) vs. 1-specificity (false-positive rate) across 
a range of values of the marker. The sensitivity and 
specificity of BMDDTX in detecting central osteoporosis 
were calculated by creating dichotomous variables for 
each central site. Using the study criteria, participants 
deemed to have normal or healthy central bone 
density, classified by the study criteria as osteoporotic, 
represented the false-positive rate. Participants with 
normal or healthy bone density, classified by the study 
criteria as normal or healthy, represented the true-
positive rate. In the context of this study, the presence 
or absence of hip or spine osteoporosis was considered 
the diagnostic criterion for constructing the ROC curves. 
ROC analyses were used to determine the area under 
the curve (AUC), which is an indicator of the overall 
accuracy of the diagnostic value of the test. A rough 
guide used to classify the accuracy of a diagnostic test 
is the traditional academic point system: fail: 0.50-0.60; 
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poor: 0.60-0.70; fair: 0.70-0.80; good: 0.80-0.90; and 
excellent: 0.90-1.00.
The optimal cut-off point for the best trade-off is the 
value with the highest accuracy that maximises the 
sum of the sensitivity and specificity (Youden’s index). 
Youden’s index (YI) can be defined as J = sensitivity – 
(1-specificity), and ranges between 0 and 1. Complete 
separation of the distribution of the marker values for 
the diseased and healthy population results in J = 1, 
whereas a complete overlap gives J = 0. The YI is easy 
to apply, and does not require further information, 
such as prevalence rates and decision error costs. 
A second method was also used to calculate the 
shortest distance to the (0.1) point on the ROC curve: 
[(1-sensitivity)2 + (1-specificity)2].
The National Osteoporosis Society (NOS) recommends 
that peripheral densitometers use a 90% sensitivity 
cut-off point. A second cut-off point was established 
at 90% sensitivity. Using statistics from both methods 
described above, an ideal threshold was established 
for peripheral densitometer measurements. 
Primary analyses were performed without covariate 
adjustments to reflect the standard use of test results in 
a research environment. All analyses were two-tailed, 




The demographic data and number of subjects for 
each classified group are summarised in Table I.
The mean age ± SD of the whole study group was 62.47 
± 9.39 years, with a mean height of 1.54 ± 0.06 m, a mean 
weight of 68.46 ± 17.70 kg, and a mean BMI of 28.73 
± 7.24 kg/m2. The mean forearm BMDDTX was 0.423 
± 0.10 g/cm2 vs. mean BMDDXA of 0.624 ± 0.09 g/cm
2 
(32.2% lower recorded value opposed to BMDDXA 
values). According to the central BMDDXA results, the 
overall prevalence of osteoporosis was 41.3% (19.6% 
with osteoporosis of the spine, 8.2% with osteoporosis of 
the hip, and 13.6% with osteoporosis at both sites), while 
58.7% had normal levels of bone mass (Table I).
The Pearson correlation coefficient between forearm 
BMDDTX and forearm BMDDXA was r = 0.71, p-value < 0.01 
(data not shown). Strong positive correlation 
coefficients were revealed for the relationship of 
BMDDTX at the forearm with BMD at the hip (range from 
r = 0.53, p-value < 0.01 to r = 0.61, p-value < 0.01) and 
spine (r = 0.54, p-value < 0.01). 
Bland-Altman plots
Results from the Bland-Altman plots are presented 
in Figure 1. The limits of agreement, determined by 
mean difference ± 1.96 SD, for BMD data, were 0.04 
and 0.31 g/cm2, and the mean difference ± SD was 
0.177 ± 0.07.13,14 Approximately 97% (96.55%) of all the 
differences lay between the limits of agreement. 
Receiver operating curves analysis
The utility of peripheral bone densitometry to discrimi-
nate between subjects with normal or osteoporotic 
bone density, at the spine or hip site, was examined 
using ROC analysis (Figure 2). 
The overall performance of the ROC analysis was 
quantified by computing the AUC. An area of 1.0 
represents a perfect test fit, while 0.5 indicates a 
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Age (years) 62.47 ± 9.39 60.69 ± 7.90 62.81 ± 8.52 64.20 ± 12.04 68.68 ± 12.11† 184
Height (m) 1.54 ± 0.06 1.55 ± 0.06 1.55 ± 0.05 1.55 ± 0.05 1.50 ± 0.06† 184
Weight (kg) 68.46 ± 17.70 73.85 ± 18.57 65.91 ± 11.36 60.31 ± 16.35† 53.92 ± 10.36† 184
BMI (kg/m2) 28.73 ± 7.24 30.75 ± 7.74 27.50 ± 4.72 25.08 ± 6.50 † 24.08 ± 4.92 † 184
DXA total forearm BMD (g/cm2) 0.505 ± 0.08 0.529 ± 0.06 0.480 ± 0.07 0.461 ± 0.09 † 0.391 ± 0.07 † 86
DXA distal forearm BMD (g/cm2) 0.624 ± 0.09 0.649 ± 0.07 0.581 ± 0.08† 0.595 ± 0.11 0.503 ± 0.11† 86
DXA ultra distal forearm BMD (g/cm2) 0.367 ± 0.06 0.387 ± 0.05 0.354 ± 0.05 0.318 ± 0.07† 0.276 ± 0.05† 86
DXA lumbar spine BMD (g/cm2) 0.845 ± 0.15 0.931 ± 0.11 0.703 ± 0.05† 0.874 ± 0.10 0.664 ± 0.07† 184
DXA total hip left BMD (g/cm2) 0.831 ± 0.14 0.900 ± 0.11 0.806 ± 0.10† 0.677 ± 0.14† 0.661 ± 0.07† 184
DXA total hip right BMD (g/cm2) 0.831 ± 0.14 0.899 ± 0.11 0.803 ± 0.10† 0.662 ± 0.14† 0.670 ± 0.07† 184
DXA femoral neck left BMD (g/cm2) 0.724 ± 0.13 0.787 ± 0.10 0.707 ± 0.09† 0.598 ± 0.18† 0.554 ± 0.05† 184
DXA femoral neck right BMD (g/cm2) 0.741 ± 0.14 0.804 ± 0.10 0.715 ± 0.10† 0.584 ± 0.15† 0.594 ± 0.12† 184
DTX-200 forearm BMD (g/cm2) 0.423 ± 0.10 0.464 ± 0.100 0.391 ± 0.08† 0.380 ± 0.08† 0.319 ± 0.04† 184
*Osteoporosis diagnosed according to gold standard (dual-energy X-ray absorptiometry), †: Indicates significant difference from normal bone mineral density, p-value < 0.05,  
BMI: body mass index, DXA: dual-energy X-ray absorptiometry, BMD: bone mineral density
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performance that was no different from chance. 
The AUC with regard to the hip (Figure 2a) 
was 0.818 (0.747-0.888 95% CI), whereas the 
overall performance fit for the spine (Figure 
2b) was an AUC of 0.771 (0.697-0.845 95% CI). 
Maximum efficiency was at 77.50% sensitivity 
and 81.25% specificity with regard to the hip, 
and 65.57% sensitivity and 84.55% specificity for 
the spine. Based on the guidelines detailed in 
the methodology section, the value of the hip 
AUC suggests that using BMDDTX represents good 
accuracy, while the AUC value for the spine 
represents fair accuracy. The YI was 0.588 and 
0.501 for the hip and spine respectively. 
The ROC curve analyses returned a maximum 
or optimum cut-off point at a distal forearm 
BMD (BMDDTX) of 0.370 g/cm
2 for possible hip 
osteoporosis, and an optimum cut-off point 
of 0.371 g/cm2 for the spine. Using these cut-
off values, participants were then classified 
as having normal central BMD, or having 
central osteoporosis, at either the hip or spine. 
Classification statistics are summarised in Table 
II and III.
ROC analyses depicted the positive likelihood ratio 
(LR) for the hip (3.986) and spine (4.139), while the 
negative LR was 0.279 and 0.427, for the hip and spine, 
respectively. The proportion of women with a positive 
BMDDTX indication of hip osteoporosis that was correctly 
diagnosed [i.e. positive predictive value (PPV)] was 
0.525 (52.5%), while PPV for the spine was 0.672 (67.2%). 
In contrast, the negative predictive value (NPV) (the 
proportion of women with normal BMD who were 
correctly diagnosed) for the hip and spine was 0.928 
(92.8%) and 0.825 (82.5%) respectively. Approximately 
35% of the women evaluated by peripheral 
measurements were classified in different diagnostic 
strata, when evaluated by central DXA using the 
optimum hip cut-off value. The misclassification rate 
for the spine was higher, with approximately 49% of the 
women being misdiagnosed. The odds ratio for the hip 
was 14.27, while that of the spine was 9.70. 
ROC analysis was repeated to establish an alternative 
threshold: having 90% sensitivity. This value was identified 
as 0.414 g/cm2 for the hip and 0.475 g/cm2 for the 
Figure 1: Bland-Altman plots for the difference vs. the mean bone 

































Fig 2A Fig 2B
Figure 2: Receiver operating curve showing the diagnostic validity of the forearm bone density measurement in identifying osteoporosis at the hip 
(2a), or spine (2b), in postmenopausal women. 
Table II: Performance of BMDDTX as a diagnostic test for the presence of 
osteoporosis, at either the hip or lumbar spine, using optimum cut-off points
Variable Hip Spine
Absolute value (g/cm2) 0.370 0.371
Specificity (%) 81.25 (0.749-0.876) 84.55 (78.17-90.94)
Sensitivity (%) 77.50 (64.56-90.44) 65.57 (53.65-77.50)
Youden’s index 0.588 0.510
Positive predictive value 0.525 0.672
Negative predictive value 0.928 0.825
Prevalence (%) 21.74 33.15
Type I error rate or false positive rate (%) 19.44 15.45
Type II error rate or false negative rate (%) 22.50 36.07
Positive likelihood ratio 3.986 4.139
Negative likelihood ratio 0.279 0.427
Misclassification (%) 34.78% 48.91%
Relative risk 7.298 3.851
Odds ratio 14.270 9.703
 95% confidence interval in parentheses
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spine. The hip threshold yielded higher NPV (95.5%), yet 
it had a lower PPV (37.5%). NPV for the spine was 81.1%, 
and PPV was 38.9%. The positive LR was 0.375 for the 
hip, with a negative LR of 0.171. In contrast, both the 
positive and negative LR for the spine yielded weaker 
values (1.285 and 0.469 respectively). Women who had 
BMD values below the thresholds were 12.6 times more 
likely (odds ratio) to have osteoporosis in the hip, and 
2.7 times more likely to have osteoporosis in the spine.
Discussion
South Africa is undergoing a process of rapid 
urbanisation. Because of this and the affiliated 
lifestyle changes, the black South African population 
might now, more than ever, be considered at high 
risk of developing osteoporosis.11,17  In their study, 
Pongchaiyakul et al found lower BMD levels in urban 
men and women, compared to rural men and 
women.18 Our data revealed a disconcertingly high 
prevalence of osteoporosis (hip and/or spine) in 
black, urban postmenopausal women (≈ 41.3%). The 
prevalence of osteoporosis of the hip was 8.2%, which 
is comparable to the prevalence reported by Clowes 
et al in their study.10 Although the hip prevalence in 
our group equalled that reported by Clowes et al, the 
risk factor outcomes for hip fractures differ between 
ethnic groups, i.e. hip geometry. Some studies have 
found that a longer hip-axis length is associated with 
a higher risk of hip fractures. Hip-axis lengths seem to 
be shorter in African-Americans, compared to their 
Caucasian peers.19 However, another study found that 
hip-axis length does not explain ethnic differences in 
hip fractures.20  Drawing any definite conclusions about 
the prevalence of osteoporosis based on the hip BMD 
alone might lead to inaccurate prevalence rates. On 
the other hand, osteoporosis of the spine seems to be 
much more prevalent (≈ 20%), compared to 
that at the hip.
Despite DXA being considered the first choice in 
assessing bone density, cost and effectiveness 
do not allow for its generalised use in target 
populations. The use of peripheral densitometers 
has received much attention. However, it is 
important to establish ethnic-specific, cut-off 
values for bone density, due to the differences 
in heritability and genetic contribution to BMD 
in different ethnic groups.21 According to our 
knowledge, this is the first South African study 
that has attempted to address the lack of cut-
off values for peripheral bone density that are 
specific to sub-Saharan Africa. 
According to Miller et al, bone mass at peripheral 
sites correlates well with central sites such as 
the hip and spine, with correlation coefficients 
of between 0.6 and 0.7.22 Our study confirmed 
this highly significant relationship between BMD 
measurements of the distal forearm and hip and 
spine, and was in line with reports from previous 
studies.10,23
The overall accuracy of peripheral BMD in predicting 
hip osteoporosis (as reflected in the AUC values) 
seems to be superior to that of the spine. This was also 
found in other studies.10,24 This discordance between 
the hip and spine AUC might be explained by the 
difference in the amount of cortical and trabecular or 
cancellous bone found in each site. The lumbar spine 
is estimated to contain approximately 66% cancellous 
bone, whereas the femoral neck and distal radius 
contain approximately 25% and 30%, of cancellous 
bone, respectively. Cancellous bone is more sensitive 
to changes in bone resorption due to its more porous 
surface, therefore providing more surface area that is 
exposed to metabolic activity (bone remodelling). This 
results in the cancellous skeleton being affected first.25,26
In their article, Clowes et al reported that, in their 
population-based cohort, the Osteometer DTX-200 
identified 73% of the women, i.e. a 27% misclassification, 
in whom a treatment decision could be made without 
additional central DXA measurements, with 95% 
certainty.10 Blake and Fogelman published similar 
results, showing 38% misdiagnosis using peripheral 
densitometry.27 However, using the optimum BMDDTX cut-
off value (0.371 g/cm2) for the spine, we could place 
≈ 51% of the women in the correct diagnostic strata. 
This excludes at least half of the population from being 
referred for additional DXA scans. On the contrary, 
when we used the spine 90% sensitivity cut-off value, 
our results indicated a much higher misclassification 
rate (≈ 54%). Therefore, it is recommended that the 
0.371 g/cm2 cut-point be used on the DXADTX as a 
criterion for excluding black, urban postmenopausal 
women as having possible spine osteoporosis.
The women in our study who exhibited low distal 
forearm BMD (< 0.371 g/cm2) were ≈ 10 times more 
Table III: Performance of BMDDTX as a diagnostic test for the presence of 
osteoporosis, at either the hip or lumbar spine, using 90% sensitivity cut-off points
Variable Hip Spine
Absolute value (g/cm2) 0.414 0.475
Specificity (%) 59.00 (51.00-67.06) 38.20 (29.62-46.80)
Sensitivity (%) 90.00 (80.70-99.30) 90.00 (82.70-97.64)
Positive predictive value 0.375 0.389
Negative predictive value 0.955 0.811
Prevalence (%) 21.74 33.15
Type I error rate or false positive rate 
(%)
41.67 65.04
Type II error rate or false negative rate 
(%)
10.00 16.39
Positive likelihood ratio 2.16 1.285
Negative likelihood ratio 0.171 0.469
Misclassification (%) 20.11% 54.35%
Relative risk 8.25 2.063
Odds ratio 12.6 2.741
 95% confidence interval in parentheses
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likely to have osteoporosis of the spine, compared to 
those with BMD measurements above the threshold. 
Despite the novelty of this study, it had some shortcomings. 
We assessed black South African postmenopausal 
women, but refer throughout the paper to data on white 
postmenopausal populations. We surmise, but have no 
data to adequately support this, that the fracture risk in 
our population is similar to that of the white reference 
population at each BMD level.
The characteristics of bone loss differ between 
menopause osteoporosis and senile osteoporosis. 
One limitation of this study is that the study group was 
not divided into age increments to determine the 
accuracy of peripheral measurements for different age 
groups. In their article, Jones and Davie recommended 
that, should distal forearm BMD be used to assess large 
numbers of potentially osteoporotic women, it is best 
used in women between the ages of 60-79 years, 
since the best detection rate was found in this group 
of women.23 Future studies should investigate, and 
elaborate upon, this important point.
Measuring central BMD is the best method to identify 
patients with osteoporosis. Nevertheless, measuring 
BMD in all postmenopausal women is not cost-
effective, especially in developing countries such as 
South Africa. To reach a maximum number of women 
who are at risk, screening approaches that are easy 
to use and cost-effective, should be employed. Using 
peripheral BMD as a triage screening tool can help 
to safely exclude women with normal BMD in order 
to reduce unnecessary, expensive DXA densitometry 
measurements. To conclude, our study revealed 
that the incidence of low forearm BMD acts as a 
possible marker of central osteoporosis in black, urban 
postmenopausal women in South Africa. We suggest 
that the proposed distal forearm cut-off value (> 0.371 
g/cm2) be used to exclude women who do not have 
osteoporosis of the spine. 
“There is every reason, therefore, to apply bone mass 
measurements as widely as possible to discover those 
subjects at risk of osteoporosis in a manner that is 
effective and affordable.” – Miller et al.22
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